In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.



Qatar University and Ebn Sina Medical Company sign an MOU | Qatar University

Qatar University and Ebn Sina Medical Company sign an MOU

2023-06-01 00:00:00.0
Ibn Sena  announce collaboration.jpg

To join forces to empower pharmacy students with internship opportunities, training, and professional development.

Doha, Qatar, 31 May, 2023 Qatar University (QU) and Ebn Sina Medical Company, a subsidiary of Aamal Company Q.P.S.C., have solidified a groundbreaking partnership by signing a Memorandum of Understanding (MOU) aimed at fostering excellence and providing enriching opportunities for pharmacy students. This collaboration marks a significant step forward in advancing the field of pharmacy and nurturing the next generation of pharmaceutical professionals. The signing was in the presence of Dr. Asma Al-Thani, Vice President of the Health and Medical Sciences Sector, as well as a number of sector members, in addition to officials from Ibn Sina Medical Company.

Prof. Feras Alali, Acting Dean of the Faculty of Pharmacy, and Mr. Rashid Al-Mansoori, ebn Sina CEO, The MOU outlines a comprehensive framework for cooperation between QU and Ebn Sina Medical Company in the areas of internship programs, training initiatives, professional development, and recognition through excellence awards in line with the mission of both parties. The partnership seeks to bridge the gap between academia and industry by providing students with practical experience through seminars, workshops, and lectures, as well as training courses targeting the Qatari community, exposure to real-world scenarios, and mentorship from seasoned professionals.

 Professor Feras AlAli stated, "We appreciate the efforts made by Ibn Sina Medical Company and the members of the Faculty of Pharmacy, as well as the support of Dr. Asmaa Al Thani, Vice President of the Health and Medical Sciences Sector, in reaching this agreement. This agreement serves as a model for collaboration between the private and public sectors. Ibn Sina Medical Company is considered one of the leading companies in Qatar, serving as the distributor of pharmaceuticals in the country, while we are the first college of pharmacy in Qatar." He added: "This collaboration aims to enhance healthcare in Qatar, providing opportunities for student training and education to benefit from the skills and expertise available at Ibn Sina Medical Company. On the other hand, we will serve as the educational arm of Ibn Sina Medical Company by organizing workshops and facilitating knowledge exchange between the faculty members and the professional staff at the company."

Furthermore, since the establishment of the Faculty of Pharmacy, Ebn Sina Medical Company has sponsored awards to recognize outstanding pharmacy students who demonstrate exceptional academic performance, leadership qualities, and a commitment to advancing the field of pharmacy. These awards aim to inspire and motivate students to strive for

For his part, Mr. Rashid Al Mansoori, the CEO of Aamal Company Q.P.S.C., said, "Thank you for hosting us today to sign this memorandum of understanding. Ibn Sina Company is committed to providing the best for the community, and as a business, it is our social responsibility to offer the best to society and take care of the students by providing them with training and development opportunities that will benefit the community." Mr. Rashid Al Mansoori also visited the Faculty of Pharmacy to meet with students, professors, and the facilities of the college.

The signing of this MOU sets the stage for a fruitful and mutually beneficial partnership between Qatar University and Ebn Sina Medical Company to empower pharmacy students. By combining academic rigor with industry expertise, the collaboration seeks to produce highly skilled pharmacy professionals who will drive innovation, enhance patient care, and contribute to the advancement of the pharmaceutical field.